Aptevo Therapeutics Inc. (NASDAQ:APVO – Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 28,900 shares, a growth of 725.7% from the February 29th total of 3,500 shares. Based on an average trading volume of 91,700 shares, the days-to-cover ratio […]
StockNews.com began coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. Aptevo Therapeutics Stock Performance Shares of APVO opened at $0.14 on Thursday. The firm’s fifty day simple moving average is $0.16 and its 200-day simple […]
StockNews.com began coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a report issued on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Aptevo Therapeutics Stock Performance APVO opened at $0.15 on Wednesday. The stock’s 50 day moving average price is $0.17 and its 200 day moving average […]
Aptevo Therapeutics Inc. (NASDAQ:APVO – Get Free Report) was the target of a significant decline in short interest in January. As of January 15th, there was short interest totalling 78,900 shares, a decline of 61.3% from the December 31st total of 203,900 shares. Based on an average trading volume of 442,900 shares, the days-to-cover ratio […]
StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a research report released on Friday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners assumed coverage on Aptevo Therapeutics in a research report on Monday, October 9th. They set a buy rating for the company. […]